Evaluations & CE Credits

Similar documents
Breast Imaging! Ravi Adhikary, MD!

Screening Mammography: The Controversy, Risk Assessment and Individualized Screening recommendations. Jonathan T. Sims MD, MBA

Breast density: imaging, risks and recommendations

Breast Cancer Risk Assessment: Genetics, Risk Models, and Screening. Amie Hass, MSN, ARNP, FNP-BC Hall-Perrine Cancer Center

Tissue Breast Density

Imaging Guidelines for Breast Cancer Screening

Wellness Along the Cancer Journey: Cancer Types Revised October 2015 Chapter 2: Breast Cancer

Breast Cancer Screening Clinical Practice Guideline. Kaiser Permanente National Breast Cancer Screening Guideline Development Team

MANAGEMENT OF DENSE BREASTS. Nichole K Ingalls, MD, MPH NW Surgical Specialists September 25, 2015

Mammography and Other Screening Tests. for Breast Problems

Breast Cancer Risk Assessment and Prevention

Breast Cancer Screening and High Risk

Patient Information. Name: (Last) (First) (Middle) Address: (Street) (City) (State) (Zip) Home Phone: Cell Phone: address:

Disclosures. Breast Cancer. Breast Imaging Modalities. Breast Cancer Screening. Breast Cancer 6/4/2014

Screening Mammography: Who, what, where, when, why and how?

BAYLOR SCOTT & WHITE HEALTH GENETICS QUESTIONNAIRE PATIENT INFORMATION

Breast Cancer Screening: Changing Philosophies in Educating Women and Teens

Breast Cancer Risk Factors 8/3/2014

Breast Cancer Imaging

Screening Mammograms: Questions and Answers

Current Status of Supplementary Screening With Breast Ultrasound

High Risk Screening: A Multimodality Approach

Hereditary Cancer Risk Program

Untangling the Confusion: Multiple Breast Cancer Screening Guidelines and the Ones We Should Follow

Risk Assessment, Genetics, and Prevention

Breast Disease: What PCPs Need to Know. Eunice Cho MD FACS

CLINICAL GUIDELINES. Screening Mammography Guidelines

Evaluation & Management of PowerPoint Cover Title. the High Risk Population. High Risk Clinic

Cancer Genetics Baylor All Saints Medical Center at Fort Worth

Improving the Identification of Underserved Women at High Risk for Breast Cancer and Increasing the use of Breast MRI Screening in this Population

Public Health Live! Breast Density and Breast Cancer Risk, December 20, 2018 Transcript

Breast Cancer. Common kinds of breast cancer are

Greater Sacramento Chapter Oncology Nursing Society Newsletter

Melissa Hartman, DO Women s Health Orlando VA Medical Center

Camelia Davtyan, MD, FACP Clinical Professor of Medicine Director of Women s Health UCLA Comprehensive Health Program

RVP Medical Director Anthem Blue Cross. Provider Clinical Liaison, Oncology Solutions

BRCA Precertification Information Request Form

Breast Cancer Screening in Women at Higher-Than-Average Risk: Recommendations From the ACR

Breast Cancer Screening

PATIENT INFORMATION. (Last) (First) (Middle) (Last) (City) (State) (Zip)

Genetic Risk Evaluation and Testing Program

On the Clinical Importance of Benign Breast Disease: Causal Intermediary or Susceptibility Marker? Laura Reimers Iadeluca

BREAST CANCER d an BREAST SELF EXAM

Henda s Law. Supplemental screening for women with dense breast tissue and increased risk

Breast Cancer. Dr. Andres Wiernik 2017

BREAST DENSITY WHAT IS IT? WHY IS IT IMPORTANT? & What IOWA SF250 Means to Patients and Providers

BREAST CANCER SCREENING IS A CHOICE

Presented by: Lillian Erdahl, MD

6 OBG Management August 2015 Vol. 27 No. 8 obgmanagement.com

Breast Cancer Awareness

Screening for Breast Cancer

Breast MRI Update. Jeffrey C. Weinreb, MD, FACR Yale University School of Medicine

Health Authority Abu Dhabi

Frequently Asked Questions about Breast Density, Breast Cancer Risk, and the Breast Density Notification Law in California: A Consensus Document

How often should I get a mammogram?

Risk Assessment and Risk Management

RMF BREAST CARE MANAGEMENT ALGORITHM

Increased Risk of Breast Cancer: Screening and Prevention. Elizabeth Pritchard, MD 4/5/2017

Breast Health. Doug Martin M.D. Medical Director Dept of Radiology CRMC Quantum Radiology

What are the risk factors for breast cancer?

Cytyc Corporation - Case Presentation Archive - March 2002

The Comparative Clinical Effectiveness and Value of Supplemental Screening Tests Following Negative Mammography in Women with Dense Breast Tissue

HBOC Syndrome A review of BRCA 1/2 testing, Cancer Risk Assessment, Counseling and Beyond.

Applies to: All Aetna plans, except Traditional Choice plans. All Innovation Health plans, except indemnity plans

Breast Cancer Early Detection

Should I Get a Mammogram?

Breast Cancer. American Cancer Society

Detection to Prediction: Imaging Markers of Breast Cancer Risk

Prophylactic Mastectomy

Breast Cancer Prevention and Early Detection

RALOXIFENE Generic Brand HICL GCN Exception/Other RALOXIFENE EVISTA Is the request for the prevention (risk reduction) of breast cancer?

Breast Cancer How to reduce your risk

Breast Cancer Risk Assessment among Bahraini Women. Majida Fikree, MD, MSc* Randah R Hamadeh, BSc, MSc, D Phil (Oxon)**

Advances in Breast Cancer Diagnosis and Treatment. Heidi Memmel, MD FACS Surgical Director of Caldwell Breast Center September 26, 2015

Mousa. Israa Ayed. Abdullah AlZibdeh. 0 P a g e

Angela Gilliam, MD University of Colorado Surgical Grand Rounds November 3, 2008

Breast Cancer Awareness Presentation. MG-51647A Eli Lilly and Company. All Rights Reserved.

So, Who are the appropriate individuals that should consider genetic counseling and genetic testing?

OBJECTIVES 8/25/2017. An attempt to organize the chaos

Clinical Genetics Service

This is a summary of what we ll be talking about today.

Breast Cancer FAQ. How does Breast Cancer spread? Breast cancer spreads by invading into

The exact cause of breast cancer remains unknown, yet certain factors are linked to the chance of getting the disease. They are as below:

Breast Cancer Screening

38 accc-cancer.org March April 2017 OI. A Pathway for Identifying Women at Increased Risk for Breast Cancer...

Breast Density: Significance and Notification. Carol H. Lee Memorial Sloan-Kettering Cancer Center New York, NY

Prophylactic Mastectomy

The Comparative Clinical Effectiveness and Value of Supplemental Screening Tests Following Negative Mammography in Women with Dense Breast Tissue

National Diagnostic Imaging Symposium 2013 SAM - Breast MRI 1

The Dilemma of Breast Density in Screening

AN EXAMINATION OF CANADIAN FAMILY PHYSICIANS KNOWLEDGE AND PRACTICE PATTERNS REGARDING BREAST CANCER PREVENTION

TMIST: Frequently Asked Questions

04/10/2018 HIGH RISK BREAST LESIONS. Pathology Perspectives of High Risk Breast Lesions ELEVATED RISK OF BREAST CANCER HISTORICAL PERSPECTIVES

BREAST IMAGING and NEW IMAGING MODALITIES- A Surgeons view

Patient Education. Breast Cancer Prevention. Cancer Center

Combined Screening With Ultrasound and Mammography vs Mammography Alone in Women at Elevated Risk of Breast Cancer JAMA. 2008;299(18):

Update in Breast Cancer Screening

What s New in Breast Imaging. Jennifer A. Harvey, M.D., FACR Professor of Radiology University of Virginia

Breast Cancer Screening and Surgery. April 26, 2018 Ashley B. Simpson, DO

The Revlon / UCLA Breast Center. High Risk Program

Transcription:

Evaluations & CE Credits Nursing Contact Hours, CME and CHES credits are available. Please visit www.phlive.org to fill out your evaluation and complete the post-test. 1

Breast Density and Breast Cancer Risk December 20, 2018 Featured Speakers Michelle Azu, MD, FACS Breast Surgery New York-Presbyterian, Lawrence Hospital Columbia University Medical Center Ralph Wynn, MD, FACR Breast Imaging New York-Presbyterian Columbia University Medical Center 2

Conflict of Interest & Disclosure Statements The planners and presenters do not have any financial arrangements or affiliations with any commercial entities whose products, research or services may be discussed in this activity. No commercial funding has been accepted for this activity. Thank You to Our Supporters University at Albany School of Public Health New York State Department of Health The Public Health Live! Advisory Committee 3

Learning Objectives Describe how breast density impacts cancer risk status Identify appropriate ways to calculate individual risk status for breast cancer Explain the screening recommendations and clinical management for women with dense breasts Breast Cancer Statistics 1 in 8 women will develop breast cancer The most commonly diagnosed cancer in women The second leading cause of cancer death in women 250,000+ new cases of invasive breast cancer annually 50,000+ new cases of non-invasive cancer annually 4

Risk Factors for Breast Cancer Multiple factors contribute to risk Biological sex Age Family history Biopsies with certain diagnoses (ex= atypia, LCIS) Obesity Breast density Menstrual history Pregnancy history Genetics Breast Density and Cancer Risk Women with dense breasts statistically more likely to develop breast cancer Dense breast tissue may reflect abundance of active ductal epithelium Active ductal epithelium is where cancer cells develop 5

What are Dense Breasts? A mammographic finding Breast are considered dense if there is a lot of fibrous or glandular tissue but not much fat About 50% of women are considered to have dense breasts About 1 extra cancer per 1000 women is found in dense breast tissue vs not dense What is Breast Density? Determined during Mammogram Interpretation 6

Significant Impact on Sensitivity Significant Impact on Sensitivity 7

Factors Significantly Associated w/increased Breast Cancer Risk Up To Date: Screening Strategies and Recommendations, BI RADS Significant Impact on Sensitivity 8

We inform the patient of her breast density in her result letter. NYS Breast Density Notification Your mammogram shows that your breast tissue is dense. Dense breast tissue is very common and is not abnormal. However, dense breast tissue can make it harder to find cancer on a mammogram and may also be associated with an increased risk of breast cancer. This information about the result of your mammogram is given to you to raise awareness. Use this information to talk to your doctor about your own risks for breast cancer. At that time, ask your doctor if more screening tests might be useful, based on your risk. A report of your results was sent to your physician. 9

Why do we report breast density to the referring physician? Calculating Risk Multiple models exist Most widely used: Breast Cancer Risk Assessment Tool (aka Gail Model) 10

Calculating Risk Other models evaluate risk for genetic mutation & breast cancer risk Tyrer-Cuzick BRCAPRO CLAUS More complex Gail Model Calculates lifetime risk of breast cancer (by age 90) and risk in next 5 years 5-year risk of >1.7% chemoprevention discussions Factors in: Age, race, ethnicity, high-risk breast history, age at first menses, parity, and first-degree relative breast cancer history 11

Gail Model Limitations Not for women with extensive family history Allows for 2 first degree maternal relatives only Does not factor in paternal history Cannot have personal history of invasive breast cancer, ductal carcinoma in situ (DCIS), or lobular carcinoma in situ (LCIS) Not best if any ovarian cancer history Gail Model Limitations May not be as accurate in non-caucasians Not for women of age <35 or >85 years Good predictor of risk for populations but not for individuals Does not factor in mammographic density 12

Case 50 year old Caucasian woman family history of breast cancer in mother BRCA negative history of 1 biopsy showing atypia Menarche 13 Nulliparous Gail Model Eligibility Does the woman have a medical history of any breast cancer, or of DCIS or LCIS, or has she received previous radiation therapy to the chest for the treatment of Hodgkin Lymphoma? Y/N Does the woman have a mutation in either the BRCA1 or BRCA2 gene, or a diagnosis of a genetic syndrome that may be associated with elevated risk of breast cancer? Y/N/Unknown 13

Demographics What is the patient s age? This tool calculates risk for women between the ages of 35 and 85. What is the patient s race/ethnicity Select race What is the subrace/ethnicity or place of birth? Patient and Family History Has the woman ever had a breast biopsy? Y/N/Unknown How many breast biopsies (positive or negative) has the woman had? 1, 2 or more Has the woman ever had a breast biopsy with atypical hyperplasia? Y/N/Unknown What was the woman s age at the time of her first menstrual period? 7-11, 12-13, 14 or older What was the woman s age when she gave birth to her first child? n/a How many of the woman s first-degree relatives (mother, sisters, daughters) have had breast cancer? None, One, More than One, Unknown 14

Case (continued) 1. Does the woman have a medical history of any breast cancer, DCIS, LCIS or has she received previous radiation treatment to the chest for treatment of Hodgkin lymphoma? 2. Does the woman have a mutation in either BRCA1 or BRCA2 gene or a diagnosis of a genetic No syndrome that may be associated with elevated risk of breast cancer? 3. What is the patient s age? 50 4. What is the patient s race/ethnicity? White a. what is the sub race/ethnicity or place of birth n/a 5. Has the woman ever had a breast biopsy Yes a. How many breast biopsies (positive or native) has the woman had? 1 b. Has the woman ever had a breast biopsy with atypical hyperplasia? Yes 6. What was the woman s age at the time of her first menstrual period? 12 13 7. What was the woman s age when she gave birth to her first child? None 8. How many of the woman s first degree relatives (mother, sisters, daughters) have had breast cancer? One No 5-Year and Lifetime Risk Based on the information provided, the patient s estimated risk for developing invasive breast cancer over the next 5 years is 4.3%, presented in red since hers is higher than the average risk of 1.3% (presented in blue) for women of the same age and race/ethnicity in the general U.S. population Based on the information provided, the woman s estimated risk for developing invasive breast cancer over her lifetime (to age 90) is 34.3%, presented in red since hers is higher than the average risk of 11.2% (presented in blue) for women of the same age and race/ethnicity in the general U.S. population. 15

Tyrer-Cuzick (aka *IBIS) Calculates lifetime risk of breast cancer and risk in next 10 years Well-studied and widely available Allows for more extensive family history Factors in breast density *International Breast Cancer Intervention Study Tyrer-Cuzick Limitations Can not have personal history of invasive breast cancer or DCIS Only considers BRCA 1 and 2 genes for the risk calculation 16

IBIS Breast Density Measure IBIS Personal History 17

IBIS - BRCA Gene IBIS Family History 18

Supplemental Screening for Dense Breasts 3D Mammography Breast Ultrasound Breast MRI 3D Mammogram (Tomosynthesis) 19

Issues With Ultrasound Screening Operator dependent Coverage of entire breast Increased benign biopsy rate Additional Small Invasive Cancers 1-2 per 1000 20

Needle Biopsy Breast MRI Like ultrasound, increased sensitivity Like ultrasound, increased biopsy rate 21

Breast MRI Breast MRI 22

Breast MRI Messaging to Women with Dense Breasts Mammogram letter will describe breast density, if increased Additional screening tests can be considered Consult with your care provider if uncertain Risk assessments can be performed by your provider 23

Messaging to Women with Dense Breasts Density and other risk factors could increase breast cancer risk If "high-risk" for breast cancer, primary care provider (PCP) will guide next steps May include breast specialist Women with dense breasts are not destined to get breast cancer Resources American Cancer Society, Breast Density and Your Mammogram Report Susan G. Komen, Breast Density on a Mammogram Gail Model: https://bcrisktool.cancer.gov/ Tyrer-Cuzick: http://ibis.ikonopedia.com/ 24

Evaluations & Continuing Education: Nursing Contact Hours, CME, and CHES credits are available. Please visit www.phlive.org to fill out your evaluation and complete the post-test. Conflict of Interest Disclosure Statement: The planners and presenters do not have any financial arrangements or affiliations with any commercial entities whose products, research or services may be discussed in this activity. No commercial funding has been accepted for this activity. Thank you! Let us know how you use Public Health Live! Take a brief survey at phlive.org. Thank you! 25